Sixera Pharma AB
556901-4763ActiveSmall biotech developing first treatment for rare Netherton syndrome.
Biopharmaceutical Companysixerapharma.com
Oversigt
- 1–4
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2012
- Grundlagt
Nøglebeslutningstagere
Torbjörn Egelrud
Founder
Jean Nordström
Founder
Lennart Hansson
Founder
Beskrivelse
Sixera Pharma is a small biopharmaceutical company established in Stockholm in 2013. The company originated from a project spun out of Swedish Orphan Biovitrum (Sobi) and Arexis. Their core mission is to develop their lead compound, SXR1096, into the first available treatment for Netherton syndrome....
AUTHERA AS